XML 66 R48.htm IDEA: XBRL DOCUMENT

FINANCIAL INSTRUMENTS (Tables)

12 Months Ended

Dec. 31, 2024

Notes and other explanatory information [abstract]

Schedule of financial assets

Schedule of financial assets
		December 31,
		2023				2024				2024
		CNY				CNY				US$

Debt instruments at amortized cost:
Trade receivables: current			—				—				—
Trade receivables: non-current			—				—				—
Financial assets included in other receivables			3				15				2
Financial assets at fair value through other comprehensive income:
Bills receivable			—				—				—

Total			3				15				2

Total current			3				15				2
Total non-current			—				—				—

Schedule of financial liabilities

Schedule of financial liabilities
		December 31,				December 31,				December 31,
		2023				2024				2024
			CNY				CNY				US$

Derivatives not designated as hedging instruments:
Derivative financial liabilities (i)			—				3,996				548
Financial liabilities at amortized cost:
Trade payables			100				280				38
Financial liabilities in other payables and accruals			7,864				3,536				485
Lease liabilities			360				—				—
Due to related companies			9,069				11,361				1,557
Due to the Shareholder			85,673				78,567				10,766

Total			103,066				97,740				13,394

Total current			103,066				19,173				2,628
Total non-current			—				78,567				10,766

(i)

This represents certain warrants issued to institutional investors on February 21, 2024, which was recognized as derivative financial liabilities (not designated as hedging instruments) with a fair value of CNY6,134 (US$843)* on the issue date as the investors have the right to exercise their warrants on a cashless basis. In accordance with IAS 32, a contract settled by a single net payment (generally referred to as net cash-settled or net equity-settled as the case may be) is a financial liability and not an equity instrument. The fair value gain of derivative financial liabilities for the year ended December 31, 2024 was CNY2,138 (US$293).